PE57999A1 - S-atropisomeros de 3-heteroaril-4-(3h)-quinazolinonas - Google Patents
S-atropisomeros de 3-heteroaril-4-(3h)-quinazolinonasInfo
- Publication number
- PE57999A1 PE57999A1 PE1998000127A PE00012798A PE57999A1 PE 57999 A1 PE57999 A1 PE 57999A1 PE 1998000127 A PE1998000127 A PE 1998000127A PE 00012798 A PE00012798 A PE 00012798A PE 57999 A1 PE57999 A1 PE 57999A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- halo
- formula
- quinazolin
- fluoro
- Prior art date
Links
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- MGRVRXRGTBOSHW-UHFFFAOYSA-N (aminomethyl)phosphonic acid Chemical compound NCP(O)(O)=O MGRVRXRGTBOSHW-UHFFFAOYSA-N 0.000 abstract 1
- -1 AMINO Chemical class 0.000 abstract 1
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical class F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 abstract 1
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
SE REFIERE A UN ATROPISOMERO DE FORMULA (Ia) DONDE UNO DE "A, B Y D" ES N Y EL RESTO ES CH, n ES 1-4, UN R5 DEBE ESTAR EN POSICION ORTO, ES ALQUILO C1-C6, HALOGENO, TRIFLUOROMETILO, AMINO(CH2)m, ENTRE OTROS; m ES CERO-4; R2 ES a)UN HETEROCICLO DE 6 MIEMBROS DE FORMULA (a) "N" ES N, "K, L Y M" ES C Y N, i)SOLO UNO "K, L Y M" ES N; ii)CUANDO "K, L Y M" ES N ESTA AUSENTE R15, R16 o R17; b)HETEROCICLO DE 5 MIEMBROS DE FORMULA (b), DONDE "T" ES CH, N ,NH, O o S Y AL MENOS UNO DE "P, Q o T" ES UN HETEROATOMO c)Ph2 DE FORMULA (c), R3 ES H, HALO, CN, NO2, ENTRE OTROS; R9 ES H, HALO, CF3, ALQUILO C1-C6, ENTRE OTROS; R10 ES H o HALO; R11 Y R14 SON INDEPENDIENTEMENTE H, HALO, CF3, ALQUILO C1-C6, ENTRE OTROS; R12 ES H, CN o HALO; R13 ES H, ALQUILO C1-C6, ALQUILO C1-C6-(CO), ENTRE OTROS, R15 ES H, CN, ALQUILO C1-C6, ENTRE OTROS; R16 ES H, CN, ALQUILO C1-C6, HALO, ENTRE OTROS; R17 ES H, CN, ALQUILO C1-C6. SON COMPUESTOS PREFERIDOS (S)-6-FLUORO-2-[2-(2-FLUOROFENIL)-VINIL]-3-(2-METIL-PIRIDIN-3-IL)-3H-QUINAZOLIN-4-ONA; (S)-2-{2-[6-FLUORO-3-(2-METILPIRIDIN-3-IL)-4-OXO-3,4-DIHIDRO-QUINAZOLIN-2-IL]-VINIL}-BENZONITRILO; ENTRE OTROS Y SUS SALES. EL COMPUESTO DE FORMULA (Ia) ANTAGONIZA AL RECEPTOR DE AMPA Y SE UTILIZA PARA TRATAR O PREVENIR DEFICITS CEREBRALES POSTERIORES A UNA CIRUGIA DE DESVIACION CARDIACA E INJERTOS, ATAQUE APOPLETICO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3854097P | 1997-02-28 | 1997-02-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE57999A1 true PE57999A1 (es) | 1999-06-21 |
Family
ID=21900535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998000127A PE57999A1 (es) | 1997-02-28 | 1998-02-23 | S-atropisomeros de 3-heteroaril-4-(3h)-quinazolinonas |
Country Status (40)
| Country | Link |
|---|---|
| US (1) | US6380204B1 (es) |
| EP (1) | EP0964860B1 (es) |
| JP (1) | JP3299990B2 (es) |
| KR (1) | KR20000075812A (es) |
| CN (1) | CN1248254A (es) |
| AP (1) | AP9801202A0 (es) |
| AR (1) | AR011886A1 (es) |
| AT (1) | ATE264854T1 (es) |
| AU (1) | AU732448B2 (es) |
| BG (1) | BG103687A (es) |
| BR (1) | BR9807807A (es) |
| CA (1) | CA2282279C (es) |
| CO (1) | CO4950615A1 (es) |
| DE (1) | DE69823339T2 (es) |
| DK (1) | DK0964860T3 (es) |
| DZ (1) | DZ2438A1 (es) |
| EA (1) | EA001961B1 (es) |
| ES (1) | ES2218801T3 (es) |
| GT (1) | GT199800039A (es) |
| HN (1) | HN1998000028A (es) |
| HR (1) | HRP980108B1 (es) |
| HU (1) | HUP0000935A3 (es) |
| ID (1) | ID23435A (es) |
| IL (1) | IL130897A0 (es) |
| IS (1) | IS5141A (es) |
| MA (1) | MA24485A1 (es) |
| NO (1) | NO994178L (es) |
| NZ (1) | NZ336627A (es) |
| OA (1) | OA11088A (es) |
| PA (1) | PA8446901A1 (es) |
| PE (1) | PE57999A1 (es) |
| PL (1) | PL335307A1 (es) |
| PT (1) | PT964860E (es) |
| SK (1) | SK113199A3 (es) |
| TN (1) | TNSN98034A1 (es) |
| TR (1) | TR199902094T2 (es) |
| TW (1) | TW530055B (es) |
| UA (1) | UA58536C2 (es) |
| WO (1) | WO1998038187A1 (es) |
| ZA (1) | ZA981665B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6323208B1 (en) * | 1997-09-05 | 2001-11-27 | Pfizer Inc | Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-4-ones |
| JPH11279158A (ja) * | 1998-02-09 | 1999-10-12 | Pfizer Prod Inc | キナゾリン―４―オン誘導体の製造方法 |
| US6890930B1 (en) * | 1999-09-28 | 2005-05-10 | 3-Dimensional Pharmaceuticals, Inc. | Quinazolinones |
| CA2534405A1 (en) * | 2003-08-08 | 2005-02-17 | Ulysses Pharmaceutical Products Inc. | Halogenated quinazolinyl nitrofurans as antibacterial agents |
| US20080146562A1 (en) * | 2003-08-08 | 2008-06-19 | Ulysses Pharmaceutical Products Inc., | Halogenated quinazolinyl nitrofurans as antibacterial agents |
| GB0416730D0 (en) | 2004-07-27 | 2004-09-01 | Novartis Ag | Organic compounds |
| GB0507298D0 (en) | 2005-04-11 | 2005-05-18 | Novartis Ag | Organic compounds |
| TWI409070B (zh) * | 2005-11-04 | 2013-09-21 | Hydra Biosciences Inc | 用於調節ｔｒｐｖ３功能之化合物 |
| MX2009003673A (es) * | 2006-10-04 | 2009-04-22 | Pfizer Prod Inc | Derivados de piridido[4,3-d]pirimidin-4(3h)-ona como antagonistas de los receptores de calcio. |
| WO2008140750A1 (en) * | 2007-05-10 | 2008-11-20 | Hydra Biosciences Inc. | Compounds for modulating trpv3 function |
| WO2010111432A1 (en) * | 2009-03-24 | 2010-09-30 | Calistoga Pharmaceuticals Inc. | Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
| JP5718323B2 (ja) * | 2009-05-29 | 2015-05-13 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | 放射標識されたｐｄｅ１０阻害剤 |
| US9216177B2 (en) | 2011-02-28 | 2015-12-22 | Drexel University | Small molecular inhibitors of RAD51 recombinase and methods thereof |
| AU2021212754A1 (en) | 2020-01-29 | 2022-08-04 | Kamari Pharma Ltd. | Compounds and compositions for use in treating skin disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1298603A (en) * | 1970-04-06 | 1972-12-06 | Karamchand Premchand Private | Quinazolinone derivatives |
| US4183931A (en) * | 1977-09-08 | 1980-01-15 | Research Corporation | 2-Ketoalkyl-4(3H)-quinazolinones |
| WO1992013535A1 (en) | 1991-02-06 | 1992-08-20 | Research Corporation Technologies, Inc. | Anticonvulsant substituted quinazolones |
| ES2184960T3 (es) | 1996-05-15 | 2003-04-16 | Pfizer | Nuevas pirimidin-4-onas-(5,6)-heteroaril condensadas 2,3 disustituidas. |
| KR100375155B1 (ko) | 1996-05-15 | 2003-08-19 | 화이자 인코포레이티드 | 신규한2,3-이치환된-4(3에이치)-퀴나졸리논 |
-
1998
- 1998-02-06 NZ NZ336627A patent/NZ336627A/xx unknown
- 1998-02-06 WO PCT/IB1998/000151 patent/WO1998038187A1/en not_active Application Discontinuation
- 1998-02-06 EA EA199900689A patent/EA001961B1/ru not_active IP Right Cessation
- 1998-02-06 PT PT98901424T patent/PT964860E/pt unknown
- 1998-02-06 PL PL98335307A patent/PL335307A1/xx unknown
- 1998-02-06 TR TR1999/02094T patent/TR199902094T2/xx unknown
- 1998-02-06 EP EP98901424A patent/EP0964860B1/en not_active Expired - Lifetime
- 1998-02-06 IL IL13089798A patent/IL130897A0/xx unknown
- 1998-02-06 ID IDW990935D patent/ID23435A/id unknown
- 1998-02-06 HU HU0000935A patent/HUP0000935A3/hu unknown
- 1998-02-06 JP JP53744998A patent/JP3299990B2/ja not_active Expired - Fee Related
- 1998-02-06 US US09/380,114 patent/US6380204B1/en not_active Expired - Fee Related
- 1998-02-06 DK DK98901424T patent/DK0964860T3/da active
- 1998-02-06 DE DE69823339T patent/DE69823339T2/de not_active Expired - Fee Related
- 1998-02-06 SK SK1131-99A patent/SK113199A3/sk unknown
- 1998-02-06 CN CN98802796A patent/CN1248254A/zh active Pending
- 1998-02-06 BR BR9807807-0A patent/BR9807807A/pt not_active Application Discontinuation
- 1998-02-06 ES ES98901424T patent/ES2218801T3/es not_active Expired - Lifetime
- 1998-02-06 KR KR1019997007885A patent/KR20000075812A/ko active IP Right Grant
- 1998-02-06 AU AU57759/98A patent/AU732448B2/en not_active Ceased
- 1998-02-06 AT AT98901424T patent/ATE264854T1/de not_active IP Right Cessation
- 1998-02-06 CA CA002282279A patent/CA2282279C/en not_active Expired - Fee Related
- 1998-02-09 HN HN1998000028A patent/HN1998000028A/es unknown
- 1998-02-17 PA PA19988446901A patent/PA8446901A1/es unknown
- 1998-02-19 GT GT199800039A patent/GT199800039A/es unknown
- 1998-02-23 PE PE1998000127A patent/PE57999A1/es not_active Application Discontinuation
- 1998-02-25 CO CO98010303A patent/CO4950615A1/es unknown
- 1998-02-25 TN TNTNSN98034A patent/TNSN98034A1/fr unknown
- 1998-02-25 DZ DZ980048A patent/DZ2438A1/xx active
- 1998-02-25 MA MA24979A patent/MA24485A1/fr unknown
- 1998-02-25 TW TW087102713A patent/TW530055B/zh not_active IP Right Cessation
- 1998-02-26 AR ARP980100872A patent/AR011886A1/es unknown
- 1998-02-26 AP APAP/P/1998/001202A patent/AP9801202A0/en unknown
- 1998-02-27 HR HR980108A patent/HRP980108B1/xx not_active IP Right Cessation
- 1998-02-27 ZA ZA9801665A patent/ZA981665B/xx unknown
- 1998-06-02 UA UA99084850A patent/UA58536C2/uk unknown
-
1999
- 1999-07-30 IS IS5141A patent/IS5141A/is unknown
- 1999-08-20 OA OA9900186A patent/OA11088A/fr unknown
- 1999-08-24 BG BG103687A patent/BG103687A/xx unknown
- 1999-08-27 NO NO994178A patent/NO994178L/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE57999A1 (es) | S-atropisomeros de 3-heteroaril-4-(3h)-quinazolinonas | |
| ATE348817T1 (de) | 5-cyano-2-aminopyrimidine derivate | |
| PE20010741A1 (es) | Derivados de piperazina como antagonistas de taquicininas | |
| PE20051171A1 (es) | Inhibidores de proteina quinasas con estructura de 3-quinolincarbonitrilo | |
| PE20060243A1 (es) | Derivados de 4-amino insustituido-5-(4-urea-fenil)-pirrolotriazina | |
| NO922517D0 (no) | Terapeutiske preparater | |
| PE20040265A1 (es) | Compuestos de quinazolina utiles en terapia | |
| ATE300303T1 (de) | Verwendung von quinazolinderivate als inhibitoren der angiogenese | |
| PE20061378A1 (es) | INHIBIDORES DE LA ACTIVIDAD DE Akt | |
| EA199900693A1 (ru) | Атропизомеры 3-арил-4(3h)-хиназолинонов и их использование в качестве антагонистов амра-рецепторов | |
| ATE109481T1 (de) | Diazinderivate als angiotensin ii rezeptor antagonisten. | |
| DK1107973T3 (da) | Hidtil ukendte thieno(2,3-D)pyrimidindioner, fremgangsmåde til deres fremstilling og anvendelse deraf i terapi | |
| WO2001094345A3 (en) | Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione | |
| AR049885A1 (es) | Androgenos no esteroides, procesos para su preparacion y su utilizacion en terapia | |
| ATE300543T1 (de) | Kondensierte pyrazindionderivate als pde5 inhibitore | |
| DE60005689D1 (de) | Neue aminobenzophenone | |
| ATE302776T1 (de) | Kondensierte pyridoindolderivate | |
| CO5261560A1 (es) | Nuevos derivados de tiazolidindiona como agentes antidiabeticos | |
| ATE330958T1 (de) | Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate | |
| NO963337L (no) | Heterosykliske forbindelser og deres fremstilling og anvendelse | |
| MXPA03000887A (es) | Derivados heterociclicos fusionados como inhibidores de fosfodiesterasa. | |
| ATE297926T1 (de) | Hexahydropyrazino(1'2':1,6)-pyrido(3,4-b)indole 1,4-dion-derivate zur behandlung von cardiovaskulären erkrankungen und erektionsstörungen | |
| EA200400877A1 (ru) | 2'-гало-3',5'-диалкоксифен-1'-илимино-2-имидазолидиновые производные и их применение для лечения недержания мочи | |
| ATE62687T1 (de) | Acylaminomethylimidazo(1,2-a>pyrimidinderivate, ihre herstellung und therapeutische verwendung. | |
| ATE154601T1 (de) | 4-amino-2-(hetero)aryl-butanamide verwenbar als 5-ht1a-antagonisten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |